Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Stereotaxis

Stereotaxis’ comprehensive range of proprietary products and solutions, which are built around the technology of magnetics, have introduced a new era in cardiac interventional medicine. This era is one in which physicians are able to safely and remotely perform computerized catheter-based interventional procedures. Physicians are able to conduct these procedures using a range of “point and click”, “joystick”, “push button” and “touch screen” modes, from the control room adjacent to the patient lab, or cath lab, and outside the x-ray field that is used for all types of interventional procedures. Physicians may use partial or full automation of procedure protocols through the use of customized software. Products are designed to provide patients with enhanced outcomes, safety and access to important new therapies, as well as to improve hospital’s cath lab efficiencies and to improve physician safety, comfort and ease of use relative to conventional interventional methods.


Contact Details:
4320 Forest Park Avenue Suite 100
St. Louis
MO
63108
United States of America
Tel:866-646-2346
Fax:314-678-6159
Email:
WWW:

www.stereotaxis.com/




Loading...

Recent Publications by Stereotaxis:

Pulmonary vein isolation after left-sided pneumonectomy: technically challenging but feasible and instructive.
We present a technically challenging case of pulmonary vein isolation...
29th May, 2009
Department of Cardiology, Stereotaxis Labor, Asklepios Klinik St Georg, Europace. 2009 Mar;11(3):389-91. Epub 2009 Jan 15.
DOI Direct Link

Press Releases on Stereotaxis:

BioPortfolio Logo
Reportlinker Adds Cardiovascular Catheters and Systems - Global Market Opportunities 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Cardiovascular Catheters and Systems - Global Market Opportunities http:/
Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth 5th November, 2009 Stereotaxis, Inc.
-- Operating expenses are now expected to be below $60 million for the full year 2009. Conference Call Information The Company has scheduled a conference call for 8:30 a.m. Eastern
Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter 30th October, 2009 Stereotaxis
ST. LOUIS, Oct. 30 /PRNewswire/ -- Stereotaxis received notice that the Celsius® RMT ThermoCool® catheter has received CE Mark for distribution in the European market. The product is the fifth
Stereotaxis Announces Third Quarter 2009 Earnings Release Date and Conference Call 22nd October, 2009 Stereotaxis, Inc.
ST. LOUIS, Oct. 22 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that it will release its financial results for the third quarter ended September 30, 2009, on Thursday,
Stereotaxis Announces Underwriters' Exercise of Over-Allotment Option 12th October, 2009 Stereotaxis, Inc.
ST. LOUIS, Oct. 12 /PRNewswire-FirstCall/ -- Stereotaxis, Inc. (Nasdaq: STXS) announced today that the underwriters for the recently announced public offering of Stereotaxis common stock have

BioNews Results for Stereotaxis:

Funds worth $1M awarded to Rice, Texas Heart Institute for MRI Tracking
Medicexchange.com:  Nov 12 2009 3:28AM Matching: stereotaxis
Rice, Texas Heart Institute win $1 million grant to study MRI technology
San Francisco Business Times:  Nov 11 2009 11:21PM Matching: stereotaxis
NIH $1 million Challenge Grant to refine cell-tracking nanotube technology
News-Medical.Net:  Nov 11 2009 4:49AM Matching: stereotaxis
$1M in Stimulus Funds Awarded to Rice University, Texas Heart Institute for MRI Tracking of Stem Cells
Freshnews.com:  Nov 11 2009 1:49AM Matching: stereotaxis
$1M in Stimulus Funds Awarded to Rice University, Texas Heart Institute for MRI Tracking of Stem Cells
Yahoo! Canada:  Nov 11 2009 1:20AM Matching: stereotaxis
Promote your company here: BioNewsCast - Press Release Distribution

View more Stereotaxis news.

Stereotaxis Patents:

US Patent No.Title
6524303 Variable stiffness magnetic catheter
6902528 Method and apparatus for magnetically controlling endoscopes in body lumens and cavities
6911026 Magnetically guided atherectomy
6940379 Magnets with varying magnetization direction and method of making such magnets
6968846 Method and apparatus for refinably accurate localization of devices and instruments in scattering environments

View more Stereotaxis patents.

Stereotaxis (STXS) Financial information Links from Barchart

STXS Quote from from Barchart.com
STXS Chart from from Barchart.com
STXS Profile from from Barchart.com
STXS Opinion from from Barchart.com

View more Stereotaxis finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 269 times since April 2007, the link to the organisation's website has been followed 33 times

Recent Search Terms used to find this page: stereotaxis, Inc. list patents | .

Search for more companies in St. Louis

Search for more companies in MO



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Stereotaxis

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.